Skip to content

Active ingredient

Cabergoline

12 finished FDA listings contain Cabergoline as their only active ingredient.

FDA NDC Directory

Ingredient names as written by FDA
CABERGOLINE
Dosage forms
Tablet
Routes
Oral
Manufacturers / labelers
9
Strengths listed
.5 mg/1

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 47579

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 020664PFIZER1996-12-231
ANDA 076310STRIDES PHARMA INTL2005-12-293
ANDA 077750IVAX SUB TEVA PHARMS2007-03-072
ANDA 204735INGENUS PHARMS LLC2018-08-012
ANDA 218618AMNEAL2024-06-252
ANDA 218109SOMERSET THERAPS LLC2024-09-091
ANDA 220309RENATA2026-06-151

Official labeling on DailyMed

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.